Zacks Company Profile for Medpace Holdings, Inc. (MEDP : NSDQ) |
|
|
|
Company Description |
Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.
Number of Employees: 5,900 |
|
|
|
Price / Volume Information |
Yesterday's Closing Price: $326.03 |
Daily Weekly Monthly
 |
20 Day Moving Average: 412,065 shares |
Shares Outstanding: 28.74 (millions) |
Market Capitalization: $9,370.63 (millions) |
Beta: 1.47 |
52 Week High: $459.77 |
52 Week Low: $250.05 |
Short Interest Ratio: |
|
% Price Change |
% Price Change Relative to S&P 500 |
4 Week |
4.25% |
-0.05% |
12 Week |
7.76% |
-5.58% |
Year To Date |
-1.87% |
-7.32% |
|
|
|
|
|
|
|
General Corporate Information |
Officers
August J. Troendle - Chief Executive Officer and Chairman of the Board
Kevin M. Brady - Chief Financial Officer
Brian T. Carley - Director
Robert O. Kraft - Director
Fred B. Davenport Jr. - Director
|
|
Peer Information
Medpace Holdings, Inc. (CHCR)
Medpace Holdings, Inc. (ESRX)
Medpace Holdings, Inc. (MYDP)
Medpace Holdings, Inc. (COR)
Medpace Holdings, Inc. (GBCS)
Medpace Holdings, Inc. (LAXAF)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 58506Q109
SIC: 8731
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 07/21/25
|
|
Share - Related Items
Shares Outstanding: 28.74
Most Recent Split Date: (:1)
Beta: 1.47
Market Capitalization: $9,370.63 (millions)
|
|
|
|
|
|
EPS Information |
Dividend Information |
Analyst Coverage: No |
Dividend Yield: 0.00% |
Current Fiscal Quarter EPS Consensus Estimate: $2.98 |
Indicated Annual Dividend: $0.00 |
Current Fiscal Year EPS Consensus Estimate: $12.71 |
Payout Ratio: 0.00 |
Number of Estimates in the Fiscal Year Consensus: 5.00 |
Change In Payout Ratio: 0.00 |
Estmated Long-Term EPS Growth Rate: 4.36% |
Last Dividend Paid: NA - $0.00 |
Next EPS Report Date: 07/21/25 |
|
|
|
|